事关健康险！四家行业机构集体发声

Group 1 - The core viewpoint of the article emphasizes the growing importance of commercial health insurance as a support for the development of innovative drugs, improvement of the healthcare system, and protection for ordinary families [1][9] - A high-quality development meeting for health insurance was held in Beijing, led by the China Insurance Industry Association, with participation from various stakeholders including medical associations, experts, and representatives from pharmaceutical and insurance companies [1][9] - The meeting concluded with a collective statement from four industry organizations highlighting the key role and future plans of commercial health insurance in supporting innovative drug development and enhancing healthcare systems [1][9] Group 2 - The China Insurance Industry Association reported that the average annual compound growth rate of commercial health insurance has exceeded 20% over the past decade, with over 11,000 medical insurance products available [2][11] - It is estimated that by 2025, the total compensation amount for innovative drugs and devices from commercial health insurance will reach approximately 14.7 billion yuan, reflecting a compound annual growth rate of 70% over four years [2][11] - The association noted that commercial health insurance has included CAR-T therapies and other high-value technologies in its coverage, driven by policy support and market demand [2][11] Group 3 - The China Actuarial Society is actively working on compiling a net cost table for commercial medical insurance, which will help insurance companies in pricing and risk assessment [4][13] - The society is also conducting cost measurement and analysis for innovative drugs, establishing a regular communication mechanism with the pharmaceutical industry to enhance data sharing [4][13] - Future efforts will focus on strengthening experience analysis in commercial medical insurance and optimizing product offerings to promote high-quality development in health insurance [4][13] Group 4 - The China Banking and Insurance Asset Management Association reported that the balance of insurance funds directed towards medical health-related funds has exceeded 250 billion yuan [5][14] - By 2025, the total scale of investments in medical-related assets through various investment plans is expected to surpass 150 billion yuan, supporting the growth of medical enterprises [5][14] - The association aims to continue promoting insurance funds to support the development of the healthcare and elderly care industries, contributing to high-quality financial development [5][15] Group 5 - China Silver Insurance Technology Co. is focusing on building a new data infrastructure for health insurance, enhancing services such as product verification, risk control, and claims support [7][16] - The company has developed a comprehensive information platform for commercial health insurance, which includes various systems for data collection and risk monitoring [7][16] - Future initiatives will concentrate on optimizing health insurance product verification, integrating data between health insurance and medical insurance, and upgrading platform infrastructure [7][17]